Ongoing Trials Shows Pfizer COVID-19 Vaccine Is 91.3% Effective At Least 6 Months After 2nd Dose
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday.